Long-term follow-up of S0221, comparing alternative dose-schedules of anthracycline and taxane therapy in early breast cancer.
Saved in:
| Title: | Long-term follow-up of S0221, comparing alternative dose-schedules of anthracycline and taxane therapy in early breast cancer. |
|---|---|
| Authors: | Ali A; Division of Hematology and Oncology, Cleveland Clinic Foundation, Taussig Cancer Institute, Cleveland, OH, United States., Barlow WE; Department of Biostatistics, University of Washigton, SWOG Statistics and Data Management Center, Seattle, WA, United States., Moore HCF; Division of Hematology and Oncology, Cleveland Clinic Foundation, Taussig Cancer Institute, Cleveland, OH, United States., Hobday TJ; Division of Hematology and Oncology, Mayo Clinic Comprehensive Cancer Center, Rochester, MN, United States., Isaacs C; Division of Hematology and Oncology, Georgetown Lombardi Comprehensive Cancer Center, Washington, DC, United States., Salim M; Division of Oncology, Allan Blair Cancer Center, Regina, Saskatchewan, Canada., Albain KS; Division of Hematology and Oncology, Loyola University Chicago, Stritch School of Medicine, Chicago, IL, United States., Chew HK; Division of Hematology and Oncology, University of California-Davis Comprehensive Cancer Center, Sacramento, CA, United States., Burton GV; Division of Hematology and Oncology, Louisiana State University Health Sciences Center, Shreveport, LA, United States., Srkalovic G; Division of Hematology and Oncology, University of Michigan Health - Sparrow, Herbert-Herman Cancer Center, Lansing, MI, United States., McGregor BA; Dvision of Hematology and Oncology, Dana-Farber Cancer Institute, Boston, MA, United States., Flaherty LE; Division of Hematology and Oncology, Karmanos Cancer Institute/Wayne State University, Detroit, MI, United States., Lew DL; Department of Biostatistics, University of Washigton, SWOG Statistics and Data Management Center, Seattle, WA, United States., Gralow JR; American Society of Clinical Oncology Association for Clinical Oncology, Alexandria, VA, United States., Hortobagyi GN; Division of Hematology and Oncology, University of Texas MD Anderson Cancer Center, Houston, TX, United States., Sharma P; Division of Hematology and Oncology, University of Kansas Medical Center, Kansas City, KS, United States., Pusztai L; Division of Hematology and Oncology, Yale Cancer Center, New Haven, CT, United States., Budd GT; Division of Hematology and Oncology, Cleveland Clinic Foundation, Taussig Cancer Institute, Cleveland, OH, United States. |
| Source: | JNCI cancer spectrum [JNCI Cancer Spectr] 2026 Mar 03; Vol. 10 (2). |
| Publication Type: | Journal Article; Randomized Controlled Trial; Comparative Study; Multicenter Study |
| Journal Info: | Publisher: Oxford University Press Country of Publication: England NLM ID: 101721827 Publication Model: Print Cited Medium: Internet ISSN: 2515-5091 (Electronic) Linking ISSN: 25155091 NLM ISO Abbreviation: JNCI Cancer Spectr Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
